-
access to powerful GPUs in the KI network. No development and no exploration can happen without a cutting edge back-end with a database storing all data. Your mission As a backend & data engineer, you will
-
, Tumor and Cell Biology at Karolinska Institutet (KI) announces an opportunity to join the Bionanomaterial Technology Laboratory and research group of Principal Investigator Assoc. Professor Dr. Georgios A
-
, phenotypic profiling and image analysis. The applicant will be expected to regularly present and communicate the scientific results achieved both in a written and oral format, develop current protocols
-
technology, molecular biology, or AI. Have experience in research with advanced imaging techniques at research infrastructures, as well as an in-depth understanding of working with various imaging techniques
-
. As part of the Dura-store project we aim to use bio-inspired solutions to address fundamental limitations of the current manifestations of the technology in terms of data stability and dynamic data
-
interdisciplinary technology development. Suitable candidates should have extensive experience with molecular biology methods such as RNA-Seq, ATAC-Seq, molecular cloning and RNA biology. Research experience with
-
the following documents in English or Swedish: A complete resumé, including date of the thesis defence, title of the thesis, previous academic positions, academic title, current position, academic distinctions
-
applicant has experience in gene editing with Cas9-mediated engineering. It is expected that the candidate should be able to prioritize tasks, meet deadlines, and work independently. Good knowledge in English
-
imaging technology with PET enables us to detect and map pathological changes in the brain in Alzheimer´s disease and other dementia diseases long before symptoms of memory problems occur. Our studies aim
-
a unique automated robotic lab for high-capacity full-length scRNA-seq that can provide state-of-the-art splicing information across complex tissues. Using this scalable scRNA-seq technology, we